Insider · CIK 0001578852
Mark Elliott Boulding
officer
Files at PTCT (PTC THERAPEUTICS, INC.). First filing Dec 4, 2024, latest Oct 7, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 17
$0 bought, $17M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PTCT: PTC THERAPEUTICS, INC.
PTCTOct 9, 2026 · close 64.70
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 6Weak | PTC THERAPEUTICS, INC. | $133k 2,073 shares | -2% | +2% from low-29% from high | |
| 15Weak | PTC THERAPEUTICS, INC. | $210k 3,019 shares | -3% | +93% from low-19% from high | |
| 4Weak | PTC THERAPEUTICS, INC. | $409k 5,894 shares | -5% | +91% from low-20% from high | |
| 21Weak | PTC THERAPEUTICS, INC. | $489k 6,347 shares | -5% | +112% from low-11% from high | |
| 6Weak | PTC THERAPEUTICS, INC. | $512k 6,618 shares | -5% | +112% from low-11% from high | |
| 0Weak | PTC THERAPEUTICS, INC. | $171k 2,266 shares | -2% | +112% from low-11% from high | |
| 7Weak | PTC THERAPEUTICS, INC. | $214k 2,812 shares | -3% | +109% from low0% from high | |
| 7Weak | PTC THERAPEUTICS, INC. | $214k 3,375 shares | -3% | +83% from low-2% from high | |
| 25Weak | PTC THERAPEUTICS, INC. | $1.6M 24,921 shares | -20% | +87% from low0% from high | |
| 30Weak | PTC THERAPEUTICS, INC. | $2.9M 47,249 shares | -39% | +89% from low0% from high | |
| 6Weak | PTC THERAPEUTICS, INC. | $137k 2,813 shares | -3% | +51% from low-15% from high | |
| 0Weak | PTC THERAPEUTICS, INC. | $130k 2,812 shares | -3% | +40% from low-21% from high | |
| 16Weak | PTC THERAPEUTICS, INC. | $827k 15,521 shares | -13% | +66% from low-3% from high | |
| 33Weak | PTC THERAPEUTICS, INC. | $4.0M 75,420 shares | -51% | +63% from low-5% from high | |
| 21Weak | PTC THERAPEUTICS, INC. | $148k 2,947 shares | -3% | +56% from low-3% from high | |
| 21Weak | PTC THERAPEUTICS, INC. | $159k 3,541 shares | -3% | +38% from low-14% from high | |
| 40Moderate | PTC THERAPEUTICS, INC. | $5.0M 95,908 shares | -102% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +1,638 | $39.42 | $65k | 106,910 | 5 d ago |
| Oct 5, 2026 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,638 | $64.03 | $105k | 105,272 | 5 d ago |
| Oct 6, 2026 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +435 | $39.42 | $17k | 105,707 | 5 d ago |
| Oct 6, 2026 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -435 | $64.16 | $28k | 105,272 | 5 d ago |
| Oct 5, 2026 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,638 | $0.00 | $0 | 2,894 | 5 d ago |
| Oct 6, 2026 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -435 | $0.00 | $0 | 2,459 | 5 d ago |
| Feb 19, 2026 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -588 | $68.54 | $40k | 107,643 | Feb 23, 2026 |
| Feb 19, 2026 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,629 | $69.82 | $114k | 106,014 | Feb 23, 2026 |
| Feb 19, 2026 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -212 | $68.54 | $15k | 105,802 | Feb 23, 2026 |
| Feb 19, 2026 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -590 | $69.82 | $41k | 105,212 | Feb 23, 2026 |
| Feb 17, 2026 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +2,813 | $25.69 | $72k | 114,125 | Feb 19, 2026 |
| Feb 17, 2026 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -2,811 | $69.29 | $195k | 111,314 | Feb 19, 2026 |
| Feb 17, 2026 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -2 | $70.13 | $140 | 111,312 | Feb 19, 2026 |
| Feb 18, 2026 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -3,081 | $69.36 | $214k | 108,231 | Feb 19, 2026 |
| Feb 17, 2026 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,813 | $0.00 | $0 | 22,501 | Feb 19, 2026 |
| Jan 8, 2026 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -2,482 | $76.56 | $190k | 115,177 | Jan 12, 2026 |
| Jan 8, 2026 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -265 | $77.07 | $20k | 114,912 | Jan 12, 2026 |
| Jan 8, 2026 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,286 | $76.45 | $98k | 113,626 | Jan 12, 2026 |
| Jan 9, 2026 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,521 | $77.46 | $118k | 112,105 | Jan 12, 2026 |
| Jan 9, 2026 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -686 | $78.71 | $54k | 111,419 | Jan 12, 2026 |
| Jan 9, 2026 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -107 | $79.52 | $8,509 | 111,312 | Jan 12, 2026 |
| Jan 6, 2026 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,739 | $76.95 | $134k | 119,162 | Jan 8, 2026 |
| Jan 7, 2026 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,503 | $77.48 | $116k | 117,659 | Jan 8, 2026 |
| Jan 7, 2026 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +2,625 | $38.10 | $100k | 120,284 | Jan 8, 2026 |
| Jan 7, 2026 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,638 | $77.11 | $126k | 118,646 | Jan 8, 2026 |
| Jan 7, 2026 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -949 | $77.91 | $74k | 117,697 | Jan 8, 2026 |
| Jan 7, 2026 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -38 | $78.60 | $2,987 | 117,659 | Jan 8, 2026 |
| Jan 7, 2026 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +751 | $38.10 | $29k | 118,410 | Jan 8, 2026 |
| Jan 7, 2026 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -471 | $77.10 | $36k | 117,939 | Jan 8, 2026 |
| Jan 7, 2026 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -269 | $77.92 | $21k | 117,670 | Jan 8, 2026 |
| Jan 7, 2026 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -11 | $78.98 | $869 | 117,659 | Jan 8, 2026 |
| Jan 7, 2026 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,625 | $0.00 | $0 | 751 | Jan 8, 2026 |
| Jan 7, 2026 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -751 | $0.00 | $0 | 0 | Jan 8, 2026 |
| Jan 2, 2026 | PTCT PTC THERAPEUTICS, INC. | AGrant or award Common Stock10b5-1 | +17,000 | $0.00 | $0 | 120,901 | Jan 6, 2026 |
| Jan 5, 2026 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +2,266 | $39.42 | $89k | 123,167 | Jan 6, 2026 |
| Jan 5, 2026 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,123 | $74.92 | $84k | 122,044 | Jan 6, 2026 |
| Jan 5, 2026 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,035 | $76.10 | $79k | 121,009 | Jan 6, 2026 |
| Jan 5, 2026 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -108 | $76.79 | $8,293 | 120,901 | Jan 6, 2026 |
| Jan 2, 2026 | PTCT PTC THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +42,500 | $0.00 | $0 | 42,500 | Jan 6, 2026 |
| Jan 5, 2026 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,266 | $0.00 | $0 | 9,063 | Jan 6, 2026 |
| Nov 17, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +2,812 | $25.69 | $72k | 106,713 | Nov 19, 2025 |
| Nov 17, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,843 | $75.64 | $139k | 104,870 | Nov 19, 2025 |
| Nov 17, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -777 | $76.53 | $59k | 104,093 | Nov 19, 2025 |
| Nov 17, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -192 | $77.18 | $15k | 103,901 | Nov 19, 2025 |
| Nov 17, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,812 | $0.00 | $0 | 25,314 | Nov 19, 2025 |
| Oct 7, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +3,375 | $38.10 | $129k | 107,276 | Oct 9, 2025 |
| Oct 7, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,757 | $62.89 | $110k | 105,519 | Oct 9, 2025 |
| Oct 7, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,306 | $63.80 | $83k | 104,213 | Oct 9, 2025 |
| Oct 7, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -312 | $64.97 | $20k | 103,901 | Oct 9, 2025 |
| Oct 7, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -3,375 | $0.00 | $0 | 3,376 | Oct 9, 2025 |
| Oct 3, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +18,124 | $39.42 | $714k | 122,025 | Oct 7, 2025 |
| Oct 3, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -3,100 | $64.43 | $200k | 118,925 | Oct 7, 2025 |
| Oct 3, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -6,124 | $65.47 | $401k | 112,801 | Oct 7, 2025 |
| Oct 3, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -7,400 | $66.44 | $492k | 105,401 | Oct 7, 2025 |
| Oct 3, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,500 | $67.15 | $101k | 103,901 | Oct 7, 2025 |
| Oct 3, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +2,266 | $39.42 | $89k | 106,167 | Oct 7, 2025 |
| Oct 3, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -536 | $64.43 | $35k | 105,631 | Oct 7, 2025 |
| Oct 3, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -824 | $65.73 | $54k | 104,807 | Oct 7, 2025 |
| Oct 3, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -906 | $66.63 | $60k | 103,901 | Oct 7, 2025 |
| Oct 3, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +2,265 | $39.42 | $89k | 106,166 | Oct 7, 2025 |
| Oct 3, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -550 | $64.44 | $35k | 105,616 | Oct 7, 2025 |
| Oct 3, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -838 | $65.72 | $55k | 104,778 | Oct 7, 2025 |
| Oct 3, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -877 | $66.67 | $58k | 103,901 | Oct 7, 2025 |
| Oct 6, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +2,266 | $39.42 | $89k | 106,167 | Oct 7, 2025 |
| Oct 6, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -2,266 | $65.07 | $147k | 103,901 | Oct 7, 2025 |
| Oct 3, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -18,124 | $0.00 | $0 | 18,126 | Oct 7, 2025 |
| Oct 3, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,266 | $0.00 | $0 | 15,860 | Oct 7, 2025 |
| Oct 3, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,265 | $0.00 | $0 | 13,595 | Oct 7, 2025 |
| Oct 6, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,266 | $0.00 | $0 | 11,329 | Oct 7, 2025 |
| Sep 11, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +17,838 | $38.10 | $680k | 121,739 | Sep 15, 2025 |
| Sep 11, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -17,838 | $61.00 | $1.1M | 103,901 | Sep 15, 2025 |
| Sep 11, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +2,356 | $38.10 | $90k | 106,257 | Sep 15, 2025 |
| Sep 11, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -2,356 | $61.00 | $144k | 103,901 | Sep 15, 2025 |
| Sep 11, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +2,470 | $38.10 | $94k | 106,371 | Sep 15, 2025 |
| Sep 11, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -2,470 | $61.00 | $151k | 103,901 | Sep 15, 2025 |
| Sep 12, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +22,661 | $38.10 | $863k | 126,562 | Sep 15, 2025 |
| Sep 12, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -22,117 | $61.33 | $1.4M | 104,445 | Sep 15, 2025 |
| Sep 12, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -544 | $62.09 | $34k | 103,901 | Sep 15, 2025 |
| Sep 12, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +1,019 | $38.10 | $39k | 104,920 | Sep 15, 2025 |
| Sep 12, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,019 | $61.31 | $62k | 103,901 | Sep 15, 2025 |
| Sep 12, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +905 | $38.10 | $34k | 104,806 | Sep 15, 2025 |
| Sep 12, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -905 | $61.21 | $55k | 103,901 | Sep 15, 2025 |
| Sep 11, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -17,838 | $0.00 | $0 | 36,162 | Sep 15, 2025 |
| Sep 11, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,356 | $0.00 | $0 | 33,806 | Sep 15, 2025 |
| Sep 11, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,470 | $0.00 | $0 | 31,336 | Sep 15, 2025 |
| Sep 12, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -22,661 | $0.00 | $0 | 8,675 | Sep 15, 2025 |
| Sep 12, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,019 | $0.00 | $0 | 7,656 | Sep 15, 2025 |
| Sep 12, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -905 | $0.00 | $0 | 6,751 | Sep 15, 2025 |
| Aug 15, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +2,813 | $25.69 | $72k | 106,714 | Aug 19, 2025 |
| Aug 15, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -2,813 | $48.58 | $137k | 103,901 | Aug 19, 2025 |
| Aug 15, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,813 | $0.00 | $0 | 24,899 | Aug 19, 2025 |
| May 15, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +1,929 | $25.69 | $50k | 105,830 | May 19, 2025 |
| May 15, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,929 | $46.18 | $89k | 103,901 | May 19, 2025 |
| May 16, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +883 | $25.69 | $23k | 104,784 | May 19, 2025 |
| May 16, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -883 | $46.02 | $41k | 103,901 | May 19, 2025 |
| May 15, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,929 | $0.00 | $0 | 28,595 | May 19, 2025 |
| May 16, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -883 | $0.00 | $0 | 27,712 | May 19, 2025 |
| Mar 12, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +13,126 | $33.02 | $433k | 117,027 | Mar 14, 2025 |
| Mar 12, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -13,126 | $53.31 | $700k | 103,901 | Mar 14, 2025 |
| Mar 12, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +2,395 | $33.02 | $79k | 106,296 | Mar 14, 2025 |
| Mar 12, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -2,395 | $53.23 | $127k | 103,901 | Mar 14, 2025 |
| Mar 12, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -13,126 | $0.00 | $0 | 0 | Mar 14, 2025 |
| Mar 12, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,395 | $0.00 | $0 | 0 | Mar 14, 2025 |
| Mar 10, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +45,392 | $33.02 | $1.5M | 149,293 | Mar 12, 2025 |
| Mar 10, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -45,392 | $53.15 | $2.4M | 103,901 | Mar 12, 2025 |
| Mar 10, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +11,398 | $33.02 | $376k | 115,299 | Mar 12, 2025 |
| Mar 10, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -11,398 | $53.12 | $605k | 103,901 | Mar 12, 2025 |
| Mar 10, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +11,249 | $25.69 | $289k | 115,150 | Mar 12, 2025 |
| Mar 10, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -3,487 | $52.24 | $182k | 111,663 | Mar 12, 2025 |
| Mar 10, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -7,762 | $53.05 | $412k | 103,901 | Mar 12, 2025 |
| Mar 11, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +5,662 | $33.02 | $187k | 109,563 | Mar 12, 2025 |
| Mar 11, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -5,662 | $53.02 | $300k | 103,901 | Mar 12, 2025 |
| Mar 11, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +1,719 | $33.02 | $57k | 105,620 | Mar 12, 2025 |
| Mar 11, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,719 | $53.01 | $91k | 103,901 | Mar 12, 2025 |
| Mar 10, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -45,392 | $0.00 | $0 | 18,788 | Mar 12, 2025 |
| Mar 10, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -11,398 | $0.00 | $0 | 4,114 | Mar 12, 2025 |
| Mar 10, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -11,249 | $0.00 | $0 | 33,751 | Mar 12, 2025 |
| Mar 11, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -5,662 | $0.00 | $0 | 13,126 | Mar 12, 2025 |
| Mar 11, 2025 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,719 | $0.00 | $0 | 2,395 | Mar 12, 2025 |
| Feb 19, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,333 | $50.10 | $67k | 105,515 | Feb 21, 2025 |
| Feb 20, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,614 | $50.12 | $81k | 103,901 | Feb 21, 2025 |
| Jan 7, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,543 | $45.34 | $70k | 108,846 | Jan 10, 2025 |
| Jan 8, 2025 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,998 | $44.50 | $89k | 106,848 | Jan 10, 2025 |
| Jan 3, 2025 | PTCT PTC THERAPEUTICS, INC. | AGrant or award Common Stock | +18,000 | $0.00 | $0 | 110,389 | Jan 7, 2025 |
| Jan 3, 2025 | PTCT PTC THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +45,000 | $0.00 | $0 | 45,000 | Jan 7, 2025 |
| Dec 2, 2024 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +1,960 | $51.00 | $100k | 94,349 | Dec 4, 2024 |
| Dec 2, 2024 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,960 | $52.17 | $102k | 92,389 | Dec 4, 2024 |
| Dec 2, 2024 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +83,640 | $51.00 | $4.3M | 176,029 | Dec 4, 2024 |
| Dec 2, 2024 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -83,640 | $52.26 | $4.4M | 92,389 | Dec 4, 2024 |
| Dec 3, 2024 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +600 | $33.02 | $20k | 92,989 | Dec 4, 2024 |
| Dec 3, 2024 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -600 | $53.04 | $32k | 92,389 | Dec 4, 2024 |
| Dec 3, 2024 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +7,720 | $33.02 | $255k | 100,109 | Dec 4, 2024 |
| Dec 3, 2024 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -6,315 | $53.14 | $336k | 93,794 | Dec 4, 2024 |
| Dec 3, 2024 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,405 | $54.05 | $76k | 92,389 | Dec 4, 2024 |
| Dec 3, 2024 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +1,988 | $33.02 | $66k | 94,377 | Dec 4, 2024 |
| Dec 3, 2024 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,900 | $53.13 | $101k | 92,477 | Dec 4, 2024 |
| Dec 3, 2024 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -88 | $54.14 | $4,764 | 92,389 | Dec 4, 2024 |
| Dec 2, 2024 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,960 | $0.00 | $0 | 83,640 | Dec 4, 2024 |
| Dec 2, 2024 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -83,640 | $0.00 | $0 | 0 | Dec 4, 2024 |
| Dec 3, 2024 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -600 | $0.00 | $0 | 3,070 | Dec 4, 2024 |
| Dec 3, 2024 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -7,720 | $0.00 | $0 | 61,110 | Dec 4, 2024 |
| Dec 3, 2024 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,988 | $0.00 | $0 | 15,512 | Dec 4, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.